Classic peptide drug has frequently been hindered by poor bioavailability and metabolic stability. However, cutting-edge methods are driving a true transformation in peptide design. Such engineered peptides, https://explorebookmarks.com/story21942749/revolutionizing-drug-research-with-next-generation-short-proteins